Neural Noise- Science Corporation acquired Paris-based retinal implant company Pixium Vision on 25 July 2026, days after Science Corp’s Prima implant won EU CE mark approval.1
- The acquisition is intended to enhance Science Corporation’s retinal implant technology and refine its PRIMA vision-restoration system for patients with vision loss from conditions such as geographic atrophy secondary to age-related macular degeneration.1
- Commercial rollout tied to the combined technology is expected to begin in Germany, with first implantations anticipated as early as September 2026.1
- No purchase price, payment structure, or ownership terms were disclosed in the deal announcement.1
- Pixium Vision, also a maker of retinal implant technology, becomes part of Science Corp’s push to consolidate vision-restoration BCI technology following its recent European regulatory clearance for the Prima photovoltaic sub-retinal implant.1